Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Laboratory Science, Macha Research Trust, Choma, Zambia.
Hum Vaccin Immunother. 2022 Dec 31;18(1):1-6. doi: 10.1080/21645515.2021.1948784. Epub 2021 Jul 6.
With unprecedented speed, multiple vaccines against SARS-CoV-2 are available 1 year after the COVID-19 pandemic was first identified. As we push to achieve global control through these new vaccines, old challenges present themselves, including cold-chain storage, the logistics of mass vaccination, and vaccine hesitancy. Understanding how much hesitancy toward COVID-19 vaccines might occur and what factors may be driving these concerns can improve the ability of public health workers and communicators to maximize vaccine uptake. We nested a survey within a measles-rubella mass vaccination campaign in Zambia in November 2020 and asked about sentiments and beliefs toward COVID-19 and COVID-19 vaccines. Among parents bringing their children to receive a measles-rubella vaccine, we found high acceptability of COVID-19 vaccination of their children, but substantial uncertainty and hesitancy about receiving the vaccine themselves. COVID-19 vaccination hesitancy was correlated with beliefs around COVID-19 severity and risk, as well as vaccine safety and effectiveness.
在 COVID-19 大流行被首次发现一年后,多款针对 SARS-CoV-2 的疫苗已以空前的速度问世。随着我们努力通过这些新疫苗实现全球控制,旧的挑战也随之出现,包括冷链储存、大规模接种的后勤工作以及疫苗犹豫。了解对 COVID-19 疫苗的犹豫程度可能会发生什么,以及哪些因素可能导致这些担忧,可以提高公共卫生工作者和传播者最大限度地提高疫苗接种率的能力。我们在 2020 年 11 月赞比亚的麻疹-风疹大规模疫苗接种运动中嵌套了一项调查,询问了对 COVID-19 和 COVID-19 疫苗的看法和信念。在带孩子来接种麻疹-风疹疫苗的家长中,我们发现他们非常愿意为孩子接种 COVID-19 疫苗,但对自己接种疫苗存在很大的不确定性和犹豫。对 COVID-19 疫苗的犹豫与对 COVID-19 严重程度和风险的信念,以及疫苗的安全性和有效性有关。